Literature DB >> 15558411

[Sepsis management -- antibiotic therapy].

T Welte1.   

Abstract

Sepsis is one of the most frequent infectious problems at Intensive Care Units, and sepsis is associated with significant mortality. The latter could not be markedly reduced in the last years, despite a number of advances in the field of volume substitution, catecholamines, and endocrinologic therapy. The reason might be that important steps towards overcoming of sepsis are the surgical resection of infectious foci and an adequate antibiotic treatment. A critical role plays the growing resistance of pathogens against the common antibiotics. Since no major progress in the development of new antibiotics can be expected for the next years, sepsis treatment must be focused on prevention of infection, and on an optimised application of current antibiotic substances. The key factors are a broad and high dose initial treatment, a de-escalation strategy according to the clinical course, and -with exceptions- a limitation of treatment to 7 to 10 days. Rotation of antibiotics should be performed, if problems with resistances exist or no specialist for infectious diseases is available on the Intensive Care Unit.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15558411     DOI: 10.1055/s-2004-836084

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  6 in total

1.  [Antibiotic treatment of surgical intensive care patients: procalcitonin to guide duration of therapy].

Authors:  M Hochreiter; T Köhler; A-M Schweiger; F S Keck; B Bein; T von Spiegel; S Schröder
Journal:  Anaesthesist       Date:  2008-06       Impact factor: 1.041

2.  [Septic shock due to vancomycin-resistant enterococci infection. Tigecycline monotherapy].

Authors:  S Swoboda; T Hoppe-Tichy; H K Geiss; C Hainer; T H Nguyen; H-P Knaebel; M A Weigand
Journal:  Anaesthesist       Date:  2007-02       Impact factor: 1.041

Review 3.  [Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients].

Authors:  M Hochreiter; S Schroeder
Journal:  Anaesthesist       Date:  2011-07       Impact factor: 1.041

4.  Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study.

Authors:  S Schroeder; M Hochreiter; T Koehler; A-M Schweiger; B Bein; F S Keck; T von Spiegel
Journal:  Langenbecks Arch Surg       Date:  2008-11-26       Impact factor: 3.445

Review 5.  [Diagnostic markers and assessment of efficacy of antibacterial therapy].

Authors:  K-F Bodmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-04-05       Impact factor: 0.840

6.  Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial.

Authors:  Marcel Hochreiter; Thomas Köhler; Anna Maria Schweiger; Fritz Sixtus Keck; Berthold Bein; Tilman von Spiegel; Stefan Schroeder
Journal:  Crit Care       Date:  2009-06-03       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.